✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Morepen Laboratories Ltd.

MOREPENLAB

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹2,940 Cr.
P/E
31.75

Morepen Laboratories Ltd.

  • Morepen Laboratories
  • Solara Active Pharma
  • SMS Pharmaceuticals
  • TJI Pharma - Small Cap

FAQs on Morepen Laboratories Ltd. Shareprice

Morepen Laboratories has given lower returns compared to its competitors.
Morepen Laboratories has grown at ~11.64% over the last 7yrs while peers have grown at a median rate of 21.53%

Yes, Morepen Laboratories is expensive.
Latest PE of Morepen Laboratories is 31.5, while 3 year average PE is 28.84.
Also latest EV/EBITDA of Morepen Laboratories is 20.1 while 3yr average is 18.7.

View FAQ's On Business

Growth Table

  • Morepen Laboratories Ltd.
  • Solara Active Pharma
  • SMS Pharmaceuticals

Balance Sheet

  • Morepen Laboratories Ltd.
  • Solara Active Pharma
  • SMS Pharmaceuticals

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Morepen Laboratories Ltd.
  • Solara Active Pharma
  • SMS Pharmaceuticals

Cash Flow

  • Morepen Laboratories Ltd.
  • Solara Active Pharma
  • SMS Pharmaceuticals

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Morepen Laboratories Ltd.
  • Solara Active Pharma
  • SMS Pharmaceuticals

Quarterly Results

  • Morepen Laboratories Ltd.
  • Solara Active Pharma
  • SMS Pharmaceuticals

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Morepen Laboratories Ltd. Financials

Balance sheet of Morepen Laboratories is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Morepen Laboratories is increasing.
Latest net debt of Morepen Laboratories is -₹19.22 Crs as of Mar-25.
This is greater than Mar-24 when it was -₹75.06 Crs.

The profit is oscillating.
The profit of Morepen Laboratories is ₹93.25 Crs for TTM, ₹118 Crs for Mar 2025 and ₹96.16 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Morepen Laboratories latest dividend payout ratio is 9.29% and 3yr average dividend payout ratio is 9.29%

Companies resources are allocated to majorly productive assets like Plant & Machinery

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech